PUBLISHER: The Business Research Company | PRODUCT CODE: 1942483
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942483
Brain imaging modalities are techniques used to visualize the structure, function, and activity of the brain, helping doctors and researchers diagnose and better understand brain-related conditions. These methods assist in detecting brain disorders, studying brain function, and supporting treatment planning.
The key product types of brain imaging modalities include devices, accessories, and usability solutions. Brain imaging devices are advanced systems developed to obtain detailed structural images or functional information about the brain. The imaging techniques include computed tomography (CT), positron emission tomography (PET), magnetic resonance imaging (MRI), and single photon emission computed tomography (SPECT), while the modalities consist of stand-alone functional brain imaging systems and portable functional brain imaging systems. The patient groups include adults, pediatric patients, and infants, and these solutions are used by end users such as hospitals, diagnostic centers, and research institutions.
Tariffs are impacting the brain imaging modalities market by increasing the cost of imported imaging devices such as MRI, PET, and CT scanners, as well as associated accessories like contrast agents and EEG electrodes. High-cost segments and regions including North America, Europe, and Asia-Pacific face the most significant impact due to import duties. This has led to increased operational costs for hospitals and research institutes. On the positive side, tariffs have encouraged local manufacturing, innovation in imaging device production, and investment in domestic supply chains.
The brain imaging modalities market research report is one of a series of new reports from The Business Research Company that provides brain imaging modalities market statistics, including brain imaging modalities industry global market size, regional shares, competitors with a brain imaging modalities market share, detailed brain imaging modalities market segments, market trends and opportunities, and any further data you may need to thrive in the brain imaging modalities industry. This brain imaging modalities market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The brain imaging modalities market size has grown strongly in recent years. It will grow from $13.9 billion in 2025 to $14.76 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to limited availability of advanced brain imaging devices, high cost of early imaging equipment, growing awareness of neurological disorders, reliance on stationary imaging systems, increasing number of diagnostic centers.
The brain imaging modalities market size is expected to see strong growth in the next few years. It will grow to $18.55 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to technological advancements in fMRI and PET systems, rising adoption of portable and research-oriented imaging devices, growing investment in neuroimaging research, increasing integration of ai and big data analytics, expansion of hospitals and diagnostic facilities. Major trends in the forecast period include rising adoption of advanced mri and ct imaging techniques, increasing use of portable and point-of-care brain imaging systems, growing demand for pediatric and infant brain imaging solutions, integration of image processing software and patient monitoring systems, expansion of functional brain imaging for research and clinical applications.
The increasing prevalence of neurological disorders is anticipated to support the expansion of the brain imaging modality market going forward. Neurological disorders refer to medical conditions that affect the nervous system, including the brain, spinal cord, and nerves, leading to impairments in movement, sensation, cognition, or behavior. The rising number of neurological disorders can be attributed to factors such as population aging, improved diagnostic capabilities, chronic diseases, genetic influences, environmental changes, and lifestyle-related risks. Brain imaging modalities assist in diagnosing and monitoring neurological disorders by providing detailed visualizations of brain structure and function, enabling more effective treatment planning. For example, in January 2025, according to the European Brain Council, a Belgium-based non-profit organization, nearly 7 million people in Europe were living with Alzheimer's disease, with estimates suggesting this figure could double to 14 million by 2030. Consequently, the growing prevalence of neurological disorders is supporting the advancement of the brain imaging modality market.
Leading companies operating in the brain imaging modalities market are concentrating on developing innovative technologies, such as advanced neuroimaging solutions, to strengthen their competitive positioning. Neuroimaging technologies are sophisticated medical tools used to capture detailed images of the brain's structure and functional activity. For example, in February 2024, Koninklijke Philips N.V., a Netherlands-based technology company, partnered with SyntheticMR, a Sweden-based software company, to launch Smart Quant Neuro 3D. This solution delivers automated 3D quantification of neuroimaging data, real-time visualization of brain structures, and artificial intelligence integration to improve diagnostic accuracy. The innovation is designed to streamline clinical workflows, reduce image analysis time, and enhance diagnostic confidence for healthcare providers while improving patient care.
In April 2023, GE HealthCare Technologies Inc., a US-based medical technology company, acquired IMACTIS for an undisclosed amount. This acquisition is intended to enhance GE HealthCare's technological capabilities by integrating IMACTIS's innovative navigation solutions into its healthcare offerings. IMACTIS is a US-based company specializing in computer-assisted interventional radiology.
Major companies operating in the brain imaging modalities market are Hitachi Ltd, Siemens AG, Toshiba Corporation, FUJIFILM Corporation, Koninklijke Philips N.V, GE HealthCare Technologies Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Shimadzu Corporation, Canon Medical Systems Corporation, Neusoft Corporation, Agfa-Gevaert N.V., Carestream Health, Brainlab AG, Esaote SpA, NeuroLogica Corp., Swissray International Inc., Xoran Technologies LLC., Allengers Medical Systems Ltd., Konica Minolta Healthcare Americas Inc., Hi-Tech Medical Imaging
North America was the largest region in the brain imaging modalities market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain imaging modalities market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the brain imaging modalities market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The brain imaging modalities market consists of sales of structural magnetic resonance imaging (MRI), high-resolution computed tomography (CT), and functional near-infrared spectroscopy (fNIRS). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Brain Imaging Modalities Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses brain imaging modalities market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for brain imaging modalities ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The brain imaging modalities market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.